Big thinking for adjuvants.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy.Nature communications · 2025
   Article
2. A facile approach to preparing personalized cancer vaccines using iron-based metal organic framework.Frontiers in immunology · 2023
   Article
3. Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy.ACS central science · 2022
   Review
4. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.Accounts of chemical research · 2020
   Article
5. A nanoscale metal organic frameworks-based vaccine synergises with PD-1 blockade to potentiate anti-tumour immunity.Nature communications · 2020
   Article
6. Lipidation Approaches Potentiate Adjuvant-Pulsed Immune Surveillance: A Design Rationale for Cancer Nanovaccine.Frontiers in bioengineering and biotechnology · 2020
   Article
7. Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2017
   Article
8. Smart Radiation Therapy Biomaterials.International journal of radiation oncology, biology, physics · 2017
   Review
9. Enhancing vaccine effectiveness with delivery technology.Current opinion in biotechnology · 2016
   Review
10. Bio-inspired virus-like nanovesicle for effective vaccination.Human vaccines & immunotherapeutics · 2016
    Article

Corrections and comments

• Comment on
  In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity.2015

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as